title: Acute anterior uveitis after discontinuation of tocilizumab in a patient with rheumatoid arthritis.
abstract: BACKGROUND
  Tocilizumab is a humanized monoclonal anti-interleukin-6 (IL-6) receptor antibody and has been approved in Japan for the treatment of Castleman's disease, rheumatoid arthritis (RA), and systemic juvenile idiopathic arthritis. Conjunctivitis and dry eye are known ocular adverse effects, but uveitis has not been reported.
  
  
  METHODS
  A 72-year-old woman had undergone bilateral cataract surgery without complications. Six months after the surgery, she was diagnosed with RA and treated with tocilizumab infusion every 4 weeks. However, severe malaise and dizziness occurred after the third tocilizumab infusion, and the treatment was suspended. Since the symptoms associated with RA had resolved, she was followed without any medication thereafter. At 5 weeks after the third tocilizumab infusion, she developed severe anterior inflammation with hypopyon in her left eye, and her visual acuity dropped to less than 2/200. Considering her age and history of cataract surgery, endophthalmitis was suspected and a vitrectomy was performed, but no pathogens were detected from the intraocular fluid samples collected during surgery. The ocular inflammation was gradually resolved with systemic antibiotics and corticosteroids. However, severe anterior uveitis recurred in the same eye during the tapering of the systemic corticosteroids, when the aqueous humor IL-6 level was 46,100 pg/mL. The recurrent ocular inflammation was resolved with increased doses of topical and systemic corticosteroids, and the patient has since remained relapse-free. No symptom of inflammation was observed in the right eye during the follow-up period.
  
  
  CONCLUSIONS
  This case indicates a possibility that acute anterior uveitis may have been an adverse effect after the discontinuation of anti-IL-6 receptor antibody therapy in a patient with RA.
authors: Department of Ophthalmology, National Defense Medical College, Saitama, Japan.
authors: Tomohito
authors: T
authors: Sato
authors: Department of Ophthalmology, National Defense Medical College, Saitama, Japan.
authors: Shinya
authors: S
authors: Minakuchi
authors: Department of Ophthalmology and Visual science, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.
authors: Manabu
authors: M
authors: Mochizuki
authors: Department of Ophthalmology, National Defense Medical College, Saitama, Japan.
authors: Masaru
authors: M
authors: Takeuchi
keywords: interleukin-6